Endothelin-1-Induced Focal Cerebral Ischemia in the Growth Hormone/IGF-1 Deficient Lewis Dwarf Rat
Open Access
- 6 August 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 69 (11) , 1353-1362
Abstract
Aging is a major risk factor for cerebrovascular disease. Growth hormone (GH) and its anabolic mediator, insulin-like growth factor (IGF)-1, decrease with advancing age and this decline has been shown to promote vascular dysfunction. In addition, lower GH/IGF-1 levels are associated with higher stroke mortality in humans. These results suggest that decreased GH/IGF-1 level is an important factor in increased risk of cerebrovascular diseases. This study was designed to assess whether GH/IGF-1-deficiency influences the outcome of cerebral ischemia. We found that endothelin-1-induced middle cerebral artery occlusion resulted in a modest but nonsignificant decrease in cerebral infarct size in GH/IGF-1 deficient dw/dw rats compared with control heterozygous littermates and dw/dw rats with early-life GH treatment. Expression of endothelin receptors and endothelin-1-induced constriction of the middle cerebral arteries were similar in the three experimental groups. Interestingly, dw/dw rats exhibited reduced brain edema and less astrocytic infiltration compared with their heterozygous littermates and this effect was reversed by GH-treatment. Because reactive astrocytes are critical for the regulation of poststroke inflammatory processes, maintenance of the blood–brain barrier and neural repair, further studies are warranted to determine the long-term functional consequences of decreased astrocytic activation in GH/IGF-1 deficient animals after cerebral ischemia.Keywords
This publication has 83 references indexed in Scilit:
- Diverse Roles of Growth Hormone and Insulin-Like Growth Factor-1 in Mammalian Aging: Progress and ControversiesThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2012
- Aging, Atherosclerosis, and IGF-1The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2012
- The Emerging Role of IGF-1 Deficiency in Cardiovascular Aging: Recent AdvancesThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2012
- Growth Hormone and IGF-1 Deficiency Exacerbate High-Fat Diet-Induced Endothelial Impairment in Obese Lewis Dwarf Rats: Implications for Vascular AgingThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depressionNeuroscience, 2011
- Age-Associated Vascular Oxidative Stress, Nrf2 Dysfunction, and NF- B Activation in the Nonhuman Primate Macaca mulattaThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Vasoprotective Effects of Life Span-Extending Peripubertal GH Replacement in Lewis Dwarf RatsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Plasminogen activator inhibitor type 1 derived peptide, EEIIMD, diminishes cortical infarct but fails to improve neurological function in aged rats following middle cerebral artery occlusionBrain Research, 2009
- Postischemic IGF-1 Gene Transfer Promotes Neurovascular Regeneration after Experimental StrokeJournal of Cerebral Blood Flow & Metabolism, 2009
- Early disruptions of the blood–brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged ratsNeurobiology of Aging, 2008